PUMA BIOTECHNOLOGY, INC.
PBYI · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Wilson Troy Edward: Form 4
Insider disclosure · Filed · Report period 14 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- PBYI · 74587V107 - Common Stock, par value $0.0001 per share
Company details and SEC sources
CIK 0001401667 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- PBYI on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 10880 Wilshire Blvd., Suite 1700, Los Angeles, CA
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- INNOVATIVE ACQUISITIONS CORP (to 04 Oct 2011)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields